Cefepime Dihydrochloride Monohydrate

Modify Date: 2024-01-02 20:27:39

Cefepime Dihydrochloride Monohydrate Structure
Cefepime Dihydrochloride Monohydrate structure
Common Name Cefepime Dihydrochloride Monohydrate
CAS Number 123171-59-5 Molecular Weight 571.498
Density N/A Boiling Point N/A
Molecular Formula C19H28Cl2N6O6S2 Melting Point 150ºC(dec.)
MSDS N/A Flash Point N/A

 Use of Cefepime Dihydrochloride Monohydrate


Cefepime Dihydrochloride Monohydrate is a broad-spectrum cephalosporin with enhanced coverage against Gram-positive and Gram-negative bacteria.Target: AntibacterialCefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days [1]. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin and skin structure infections. Cefepime is generally well tolerated [2].

 Names

Name cefepime hydrochloride
Synonym More Synonyms

 Cefepime Dihydrochloride Monohydrate Biological Activity

Description Cefepime Dihydrochloride Monohydrate is a broad-spectrum cephalosporin with enhanced coverage against Gram-positive and Gram-negative bacteria.Target: AntibacterialCefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days [1]. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin and skin structure infections. Cefepime is generally well tolerated [2].
Related Catalog
References

[1]. Neu, H.C., Safety of cefepime: a new extended-spectrum parenteral cephalosporin. Am J Med, 1996. 100(6A): p. 68S-75S.

[2]. Wynd, M.A. and J.A. Paladino, Cefepime: a fourth-generation parenteral cephalosporin. Ann Pharmacother, 1996. 30(12): p. 1414-24.

 Chemical & Physical Properties

Melting Point 150ºC(dec.)
Molecular Formula C19H28Cl2N6O6S2
Molecular Weight 571.498
Exact Mass 570.088867
PSA 212.81000
LogP 1.12860
Storage condition Store at 0-5°C

 Safety Information

Hazard Codes Xi
Risk Phrases R36/37/38
Safety Phrases 22-26-36/37/39
RIDADR NONH for all modes of transport
HS Code 29419000

 Articles2

More Articles
A degradation study of cefepime hydrochloride in solutions under various stress conditions by TLC-densitometry.

Biomed. Chromatogr. 29(3) , 388-95, (2015)

A rapid, accurate and sensitive thin-layer chromatography (TLC) method with densitometric detection has been developed and validated for the determination of cefepime in pharmaceuticals. Chromatograph...

In vitro and in vivo antibacterial activity of Pogostone.

Chin. Med. J. 127(23) , 4001-5, (2014)

Our pervious antibacterial studies on several traditional Chinese medicines have found that Patchouli oil from Pogostemon cablin had significant antibacterial activity against methicillin-resistant St...

 Synonyms

cefepime dihydrochloride monohydrate
Cefepime hydrochloride
Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, chloride, hydrochloride, hydrate (1:1:1:1)
MFCD06804606
Axepim
1-{[(6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidinium chloride hydrochloride hydrate (1:1:1:1)
pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, inner salt, hydrochloride, hydrate (1:2:1)
(6R-(6a,7b(Z)))-1-((7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)-1-methylpyrrolidinium Chloride Monohydrochloride Monohydrate
1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)-1-methylpyrrolidinium Chloride 72-(Z)-(O-Methyloxime) Monohydrochloride Monohydrate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate dihydrochloride hydrate
Cefepime chloride hydrochloride hydrate
Cefepime (Dihydrochloride Monohydrate)
Top Suppliers:I want be here





Get all suppliers and price by the below link:

Cefepime Dihydrochloride Monohydrate suppliers


Price: ¥122/250mg

Reference only. check more Cefepime Dihydrochloride Monohydrate price